EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Effectiveness of Sequential Treatment with Zoledronic Acid Following Discontinuation of Denosumab in Osteoporosis: A Narrative Review

Hong Ouyang, Fan Yang, Wenzuo Wei, Wei Wang

Drug Design, Development and Therapy · 2025-11 · Volume 19 · 10013-10031

DOI: 10.2147/dddt.s549062 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drug Design, Development and Therapy, 2025-11. Verfasst von Hong Ouyang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrine and Metabolism, Geriatric Diseases Institute of Chengdu, Chengdu Fifth People's Hospital (The Second Clinical Medical College…. Hauptthemen laut MEDLINE: Zoledronic Acid, Denosumab, Bone Density Conservation Agents, Osteoporosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Zoledronic AcidDenosumabBone Density Conservation AgentsOsteoporosisOsteoporosis, PostmenopausalHumansBone DensityFemale

Stichwörter der Autor:innen

bone mineral densitybone transformation markersdenosumabvertebral fractureszoledronic acid

Substanzen

Zoledronic AcidDenosumabBone Density Conservation Agents

Autor:innen und Institutionen

  • Department of Endocrine and Metabolism, Geriatric Diseases Institute of Chengdu, Chengdu Fifth People's Hospital (The Second Clinical Medical College, Affiliated Fifth People's Hospital of Chengdu University of Traditio…
  • DXR Advanced Clinical Application and Collaboration Center, GE HealthCare, Shanghai, People's Republic of China.
  • Department of Endocrine and Metabolism, Chengdu Seven People's hospital, Chengdu, 611137, People's Republic of China.

Zitieren

APA

Ouyang, H., Yang, F., Wei, W., & Wang, W. (2025). Effectiveness of Sequential Treatment with Zoledronic Acid Following Discontinuation of Denosumab in Osteoporosis: A Narrative Review. Drug Design, Development and Therapy, Volume 19, 10013-10031. https://doi.org/10.2147/dddt.s549062

Vancouver

Ouyang H, Yang F, Wei W, Wang W. Effectiveness of Sequential Treatment with Zoledronic Acid Following Discontinuation of Denosumab in Osteoporosis: A Narrative Review. Drug Design, Development and Therapy. 2025;Volume 19:10013-10031. doi:10.2147/dddt.s549062

BibTeX
@article{Ouyang2025,
  author = {Ouyang, Hong and Yang, Fan and Wei, Wenzuo and Wang, Wei},
  title = {Effectiveness of Sequential Treatment with Zoledronic Acid Following Discontinuation of Denosumab in Osteoporosis: A Narrative Review},
  journal = {Drug Design, Development and Therapy},
  year = {2025},
  volume = {Volume 19},
  pages = {10013--10031},
  doi = {10.2147/dddt.s549062}
}
Kostenlos starten →